Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-100 |
DRI_Approach |
denotes |
G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. |
T2 |
101-287 |
DRI_Challenge |
denotes |
The G2019S leucine rich repeat kinase 2 (LRRK2) mutation is the most common genetic cause of Parkinson's disease (PD), clinically and pathologically indistinguishable from idiopathic PD. |
T3 |
288-457 |
DRI_Background |
denotes |
Mitochondrial abnormalities are a common feature in PD pathogenesis and we have investigated the impact of G2019S mutant LRRK2 expression on mitochondrial bioenergetics. |
T4 |
458-584 |
DRI_Background |
denotes |
LRRK2 protein expression was detected in fibroblasts and lymphoblasts at levels higher than those observed in the mouse brain. |
T5 |
585-600 |
DRI_Background |
denotes |
The presence of |
T6 |
601-613 |
Token_Label.OUTSIDE |
denotes |
G2019S LRRK2 |
T7 |
614-673 |
DRI_Background |
denotes |
mutation did not influence LRRK2 expression in fibroblasts. |
T8 |
674-704 |
DRI_Outcome |
denotes |
However, the expression of the |
T9 |
705-717 |
Token_Label.OUTSIDE |
denotes |
G2019S LRRK2 |
T10 |
718-815 |
DRI_Outcome |
denotes |
mutation in both fibroblast and neuroblastoma cells was associated with mitochondrial uncoupling. |
T11 |
816-966 |
DRI_Background |
denotes |
This was characterized by decreased mitochondrial membrane potential and increased oxygen utilization under basal and oligomycin-inhibited conditions. |
T12 |
967-1064 |
DRI_Approach |
denotes |
This resulted in a decrease in cellular ATP levels consistent with compromised cellular function. |
T13 |
1065-1216 |
DRI_Background |
denotes |
This uncoupling of mitochondrial oxidative phosphorylation was associated with a cell-specific increase in uncoupling protein (UCP) 2 and 4 expression. |
T14 |
1217-1339 |
DRI_Background |
denotes |
Restoration of mitochondrial membrane potential by the UCP inhibitor genipin confirmed the role of UCPs in this mechanism. |
T15 |
1340-1343 |
DRI_Background |
denotes |
The |
T16 |
1344-1364 |
Token_Label.OUTSIDE |
denotes |
G2019S LRRK2-induced |
T17 |
1365-1422 |
DRI_Background |
denotes |
mitochondrial uncoupling and UCP4 mRNA up-regulation were |
T18 |
1423-1445 |
Token_Label.OUTSIDE |
denotes |
LRRK2 kinase-dependent |
T19 |
1445-1525 |
DRI_Background |
denotes |
, whereas endogenous LRRK2 levels were required for constitutive UCP expression. |
T20 |
1526-1608 |
DRI_Challenge |
denotes |
We propose that normal mitochondrial function was deregulated by the expression of |
T21 |
1609-1621 |
Token_Label.OUTSIDE |
denotes |
G2019S LRRK2 |
T22 |
1622-1782 |
DRI_Challenge |
denotes |
in a kinase-dependent mechanism that is a modification of the normal LRRK2 function, and this leads to the vulnerability of selected neuronal populations in PD. |